Neovasc Inc (NVCN)

[Never_Post]

SC13DA defined -

"What Is Schedule 13D? Schedule 13D is a form that must be filed with the U.S. Securities and Exchange Commission (SEC) when a person or group acquires more than 5% of any class of a company's shares. This information must be disclosed within 10 days of the transaction."

In the latest round of financing the names were withheld (redacted). Potentially, with a greater than 5% ownership the redacted names should be disclosed this week via the filing of the required SC13DA.
Why the need for being redacted?

To continue financing a company and have your investment reduced by dilution (increase in shares with no added value), like what happened to the BSX investment (though this was part of the agreement for the acquisition of the tissue business), seems to me to be unlikely without an imminent endpoint or acquisition of the company. Otherwise, the financing company loses the investment through dilution.

Another way of looking at it is that some entity received about 25% of Neovasc for $10 million dollars when millions of dollars have been spent on developing two products, plus over $100 million in litigation settlement with Edwards. They got a bargain, but further dilution will reduce their 25% ownership rapidly.

Lastly, the value of the company has to be substantially greater than the current $33 million dollars.

Hope this makes sense despite my long run on sentences.